{
  "id": 3716,
  "url": "https://nnemf.org/research/3716-experience-with-turbulent-magnetic-field-as-a-component",
  "title": "[Experience with turbulent magnetic field as a component of breast cancer therapy].",
  "authors": [
    "V P Letiagin",
    "N V Protchenko",
    "Iu L Rybakov",
    "Ia V Dobrynin"
  ],
  "journal": "Voprosy onkologii",
  "year": "2003",
  "doi": null,
  "pmid": "14976921",
  "abstract": "No adverse side-effects were reported in an investigation of the antitumor effect of turbulent magnetic field (TMF) carried out as a component of preoperative chemoradiotherapy for breast cancer at the Center's Clinic. The study group included 114 patients with locally advanced tumors(T3, N1-N3, M0). According to the clinical, roentgenological and histological evidence on the end-results, the procedure was highly effective. Also, it was followed by shorter and less extensive postoperative lymphorrhea.",
  "effect": "benefit",
  "evidence": "low",
  "extraction": {
    "studyType": "randomized_trial",
    "studyTypeLabel": "randomized trial",
    "effectDirection": "benefit",
    "evidenceLabel": "Low",
    "population": "Patients with locally advanced breast cancer (T3, N1–N3, M0) receiving preoperative chemoradiotherapy",
    "sampleSize": "114",
    "exposure": "turbulent magnetic field (TMF) as component of preoperative chemoradiotherapy",
    "confidencePct": "66",
    "peerReviewed": "yes",
    "mainFindings": "In 114 patients with locally advanced breast cancer, turbulent magnetic field (TMF) used as a component of preoperative chemoradiotherapy was reported as highly effective based on clinical, roentgenological, and histological end-results. No adverse side-effects were reported, and postoperative lymphorrhea was described as shorter and less extensive.",
    "outcomes": [
      "Antitumor effect / treatment effectiveness (clinical",
      "roentgenological",
      "histological end-results)",
      "Adverse side-effects",
      "Postoperative lymphorrhea duration and extent"
    ],
    "limitations": [
      "Randomization not described in the abstract despite the publication type listing 'Clinical Trial'",
      "No exposure parameters reported (e.g.",
      "field strength",
      "frequency",
      "duration)",
      "No comparator/control group described",
      "Outcomes are described qualitatively without effect sizes or statistical details"
    ],
    "keywords": [
      "turbulent magnetic field",
      "TMF",
      "breast cancer",
      "preoperative chemoradiotherapy",
      "clinical trial",
      "lymphorrhea"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"randomized_trial\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": \"turbulent magnetic field (TMF) as component of preoperative chemoradiotherapy\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Patients with locally advanced breast cancer (T3, N1–N3, M0) receiving preoperative chemoradiotherapy\",\n  \"sample_size\": 114,\n  \"outcomes\": [\n    \"Antitumor effect / treatment effectiveness (clinical, roentgenological, histological end-results)\",\n    \"Adverse side-effects\",\n    \"Postoperative lymphorrhea duration and extent\"\n  ],\n  \"main_findings\": \"In 114 patients with locally advanced breast cancer, turbulent magnetic field (TMF) used as a component of preoperative chemoradiotherapy was reported as highly effective based on clinical, roentgenological, and histological end-results. No adverse side-effects were reported, and postoperative lymphorrhea was described as shorter and less extensive.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"Randomization not described in the abstract despite the publication type listing 'Clinical Trial'\",\n    \"No exposure parameters reported (e.g., field strength, frequency, duration)\",\n    \"No comparator/control group described\",\n    \"Outcomes are described qualitatively without effect sizes or statistical details\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.66,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"turbulent magnetic field\",\n    \"TMF\",\n    \"breast cancer\",\n    \"preoperative chemoradiotherapy\",\n    \"clinical trial\",\n    \"lymphorrhea\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/14976921/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=3716",
  "updated": "2026-02-13 07:34:36"
}